Atlanta, GA - In moderate- to high-risk ACS patients heading to the cath lab, deferring GP IIb/IIIa-blocker use until they are actually in the cath lab and then treating just those patients undergoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback